FDA ANDA · ANDA040516
CHLOROQUINE PHOSPHATE
Sponsor: IMPAX LABS
What this page does not claim
A drug page is a reference view of public FDA data (Drugs@FDA), reproduced as published. SPEQ is not affiliated with the FDA, adds no interpretation to the record, and nothing here is medical, legal, or regulatory advice.
APPLICATION
ANDA040516
TYPE
ANDA
ORIGINAL APPROVAL
2003-08-29
LATEST ACTION
2026-10-14
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription
Products
CHLOROQUINE PHOSPHATEPrescription
CHLOROQUINE PHOSPHATE 500MG · TABLET · ORAL
Approval history
2026-10-14Labeling · Supplement 17 · standardAP
2023-07-24Labeling · Supplement 16 · standardAP
2022-05-03Labeling · Supplement 14 · standardAP
2022-03-16Labeling · Supplement 13 · standardAP
2020-04-28Labeling · Supplement 11 · standardAP
2003-08-29OriginalAP
Source: FDA Drugs@FDA. Browse every approval SPEQ tracks →